| ²é¿´: 771 | »Ø¸´: 5 | |||
¹Å¿É¤×ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
|
[½»Á÷]
FDAÅú×¼Spectral Diagnostics ¹«Ë¾¸Ä±ä¸Ã¹«Ë¾ToÖÎÁƸÐȾÐÔÐݿ˵ĺóÆÚÁÙ´²ÊÔÑé·½°¸ ÒÑÓÐ5È˲ÎÓë
|
|
ÔÎÄÁ´½Ó£ºhttp://www.reuters.com/article/2 ... ntent=Google+Reader ·ÒëµÄ²»ºÃ£¬»¹Íû¾ÀÕýºÍº£º£¬¹²Í¬Ìá¸ß Spectral Diagnostics Inc said the U.S. health regulator approved a change in the design of a late-stage trial of its therapy for septic shock, to increase the study's ability to detect the treatment's effects. Spectral Diagnostics£¨¹âÆ×Õï¶Ï£©¹«Ë¾±íʾ£¬ÃÀ¹úÎÀÉú¼à¹Ü»ú¹¹Åú×¼¸Ã¹«Ë¾ÖÎÁƸÐȾÐÔÐݿ˺óÆÚÁÙ´²ÊÔÑéÉè¼Æ·½°¸µÄ±ä¸ü£¬ÒÔÌá¸ßÁÙ´²Ñо¿Ë®Æ½´Ó¶ø½ÒʾÁÙ´²ÁÆÐ§¡£ The trial, named EUPHRATES, will now have two interim analyses instead of one. ¸ÃÁÙ´²ÊÔÑé³ÆÎªEUPHRATES£¬½«½øÐÐÁ½ÏîÁÙ´²ÖÐÆÚ·ÖÎö£¬¶ø·ÇÒ»Ïî¡£ It tests the company's Toraymyxin, which has been approved for therapeutic use in Japan and Europe, combined with the standard of care. ´ËÁÙ´²ÊÔÑéΪ½øÐиù«Ë¾ToraymyxinµÄÁÙ´²Ñо¿£¬¸ÃÒ©ÔÚÈÕ±¾ºÍÅ·ÖÞÒѾ±»Åú×¼ÓÃÓÚÖÎÁƸÐȾÐÔÐݿˣ¬²¢½áºÏ±ê×¼»¤Àí½øÐÐÖÎÁÆ¡£ The company expects the trial to be fully enrolled by the end of 2014. ¸Ã¹«Ë¾Ô¤¼Æ2014ÄêÄêµ×½«Íê³ÉÁÙ´²ÊÔÑéÈ«²¿²¡ÀýµÄÈë×é¡£ Septic shock is a potentially dangerous fall in blood pressure because of the presence of bacteria.ÒòÓÐϸ¾ú´æÔÚ£¬¸ÐȾÐÔÐÝ¿ËÊÇѪѹϽµµÄDZÔÚ·çÏÕÒòËØ¡£ Based on the current rate of enrolment, Spectral will disclose results of the first analysis before the end of the first quarter of 2013, it said in a statement. Ôڸù«Ë¾Ò»·ÝÉùÃ÷ÖУ¬»ùÓÚĿǰÁÙ´²ÊÔÑéµÄÈë×éÂÊ£¬¸Ã¹«Ë¾½«ÔÚ2013ÄêµÚÒ»¼¾¶Èǰ¹«²¼µÚÒ»ÆÚÁÙ´²ÊÔÑéµÄ·ÖÎö½á¹û£¬ Shares of the company closed at 24.5 Canadian cents on Tuesday on the Toronto Stock Exchange. ±¾Öܶþ£¬¸Ã¹«Ë¾¹É¼ÛÔÚ¶àÂ×¶à֤ȯ½»Ò×ËùµÄÊÕÅ̼ÛΪ24.5¼ÓԪÿ¹É¡£ [ Last edited by ¹Å¿É¤× on 2012-10-19 at 16:52 ] |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
265Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑоÀú ÓжþÇøÎÄÕÂ
ÒѾÓÐ21È˻ظ´
295²ÄÁÏÇóµ÷¼Á£¬Ò»Ö¾Ô¸Î人Àí¹¤085601ר˶
ÒѾÓÐ4È˻ظ´
0856µ÷¼Á£¬ÊÇѧУ¾ÍÈ¥
ÒѾÓÐ9È˻ظ´
298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ѧУÒѾÌá½»µ½NSFC£¬»¹ÄÜÐÞ¸ÄÂð£¿
ÒѾÓÐ7È˻ظ´
²ÄÁÏѧ˶297ÒѹýËÄÁù¼¶Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ6È˻ظ´
295¸´ÊÔµ÷¼Á
ÒѾÓÐ7È˻ظ´
±¾ÈË¿¼085602 »¯Ñ§¹¤³Ì ר˶
ÒѾÓÐ20È˻ظ´

mgl20032004
½ð³æ (ÖøÃûдÊÖ)
ÀÏÆÅ×î´ó
- Ó¦Öú: 95 (³õÖÐÉú)
- ¹ó±ö: 0.02
- ½ð±Ò: 903.4
- É¢½ð: 2212
- ºì»¨: 15
- Ìû×Ó: 1122
- ÔÚÏß: 578Сʱ
- ³æºÅ: 1439898
- ×¢²á: 2011-10-13
- ÐÔ±ð: GG
- רҵ: ÆäËûÎÞ»ú·Ç½ðÊô²ÄÁÏ
2Â¥2012-10-19 17:05:52
zhtear99
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SFL-EPI: 1
- Ó¦Öú: 147 (¸ßÖÐÉú)
- ¹ó±ö: 0.662
- ½ð±Ò: 3343.9
- É¢½ð: 5190
- ºì»¨: 53
- ɳ·¢: 4
- Ìû×Ó: 1869
- ÔÚÏß: 714.6Сʱ
- ³æºÅ: 1001108
- ×¢²á: 2010-04-19
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ

3Â¥2012-10-19 18:44:36
|
4Â¥2012-10-19 22:32:36
okitworks
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ¹ó±ö: 0.845
- ½ð±Ò: 2991.4
- É¢½ð: 4438
- ºì»¨: 25
- ɳ·¢: 3
- Ìû×Ó: 1587
- ÔÚÏß: 566.7Сʱ
- ³æºÅ: 1056149
- ×¢²á: 2010-07-12
- רҵ: »úе²âÊÔÀíÂÛÓë¼¼Êõ
5Â¥2012-10-20 09:12:10
xunmeng1985
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 20 (СѧÉú)
- ¹ó±ö: 0.26
- ½ð±Ò: 6646.7
- É¢½ð: 249
- ºì»¨: 25
- Ìû×Ó: 1687
- ÔÚÏß: 180.3Сʱ
- ³æºÅ: 1051509
- ×¢²á: 2010-07-03
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯ¹¤ÓëʳƷ»¯¹¤

6Â¥2012-10-20 12:25:52













»Ø¸´´ËÂ¥
mgl20032004
ÐÁ¿àÁË 